Answer
Yes, Pfizer Limited's Conjugated Oestrogens 0.625 mg coated tablets are contraindicated in women with known, suspected or a history of breast cancer.
Sources for this answer
- Conjugated Oestrogens 0.625mg coated tabletsPfizer Limited · emc · SmPC §4.3 Contraindications · Version 1Document updated
Sources checked